In breast cancer cells the response to KDM5 inhibitors was mediated by the level of expression of ZBTB7A transcription factor, and ZBTB7A depletion sensitized basal breast cancer cells to KDM5i [101]. The gene discussed is ZBTB7A; the disease is breast cancer.